Anti-viral compounds
US10053474B2 · kind B2 · utility
0Cited by
67References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | May 5, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.